Axogen (AXGN) Shares Outstanding (Diluted Average) (2010 - 2026)
Axogen's quarterly Shares Outstanding (Diluted Average) came in at $51.6 million in Q1 2026, up 14.13% year-on-year from $45.2 million in Q1 2025, and up 12.03% quarter-over-quarter from $46.1 million in Q4 2025.
Axogen has reported Shares Outstanding (Diluted Average) for 10 years, with the latest figure at $51.6 million in Q1 2026.
- For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) rose 14.13% year-over-year to $51.6 million; the trailing twelve-month figure through Mar 2026 stood at $51.6 million (up 14.13% YoY), and the FY2025 full-year result was $46.1 million, up 4.05% from the prior year.
- Shares Outstanding (Diluted Average) for Q1 2026 stood at $51.6 million, up from $46.1 million in the prior quarter.
- The five-year high for Shares Outstanding (Diluted Average) was $51.6 million in Q1 2026, with the low at $41.8 million in Q1 2022.
- Average Shares Outstanding (Diluted Average) over 5 years is $44.2 million, with a median of $43.2 million recorded in 2024.
- Year-over-year, Shares Outstanding (Diluted Average) grew 1.42% in 2023 and advanced 14.13% in 2026.
- Tracing AXGN's Shares Outstanding (Diluted Average) over 5 years: stood at $42.1 million in 2022, then climbed by 1.89% to $42.9 million in 2023, then climbed by 3.22% to $44.3 million in 2024, then grew by 4.05% to $46.1 million in 2025, then advanced by 12.03% to $51.6 million in 2026.
- The last three Shares Outstanding (Diluted Average) figures came in at $51.6 million (Q1 2026), $46.1 million (Q4 2025), and $49.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.75 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 386.50 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.29 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.50 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 580.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 393.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 457.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Axogen | 2.00 Bn | 1.90 Bn | 46.19 Mn | 51.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 51.59 Mn |
| Dec 31, 2025 | 46.05 Mn |
| Sep 30, 2025 | 49.09 Mn |
| Jun 30, 2025 | 45.61 Mn |
| Mar 31, 2025 | 45.20 Mn |
| Dec 31, 2024 | 44.26 Mn |
| Sep 30, 2024 | 43.61 Mn |
| Jun 30, 2024 | 43.47 Mn |
| Mar 31, 2024 | 43.23 Mn |
| Dec 31, 2023 | 42.88 Mn |
| Sep 30, 2023 | 42.82 Mn |
| Jun 30, 2023 | 42.86 Mn |
| Mar 31, 2023 | 42.57 Mn |
| Dec 31, 2022 | 42.08 Mn |
| Sep 30, 2022 | 42.22 Mn |
| Jun 30, 2022 | 41.99 Mn |
| Mar 31, 2022 | 41.80 Mn |
| Dec 31, 2021 | 41.21 Mn |
| Sep 30, 2021 | 41.47 Mn |
| Jun 30, 2021 | 40.89 Mn |
| Mar 31, 2021 | 40.71 Mn |
| Dec 31, 2020 | 39.97 Mn |
| Sep 30, 2020 | 39.87 Mn |
| Jun 30, 2020 | 39.76 Mn |
| Dec 31, 2019 | 39.24 Mn |
| Jun 30, 2011 | 4.31 Mn |
| Jun 30, 2010 | 4.31 Mn |